Biomarkers for Pain in Spinal Cord Injury Patients
Completed
Conditions studied: Traumatic Spinal Cord Injury, Neuropathic Pain
In brief
The investigators propose to compare plasma protein profiles for SCI patients with/without chronic neuropathic pain in order identify biomarker(s) that are associated with this medical condition. Secondly, the investigators propose to identify a temporal relationship to initial SCI at which these biomarkers manifest. Our working hypothesis is that sustained alterations in specific inflammatory molecules are associated with chronic neuropathic pain following SCI, and that their plasma levels can serve as biomarkers to identify patients at risk for the development of neuropathic pain. Additionally the investigators are collecting skin tissue biopsy samples from patients following acute and chronic spinal cord injury to create vector-free human iPS cells from fibroblasts by direct delivery of reprogramming proteins.
Key facts
- Study ID
- NCT00913471
- Run by
- The University of Texas Health Science Center, Houston
- People needed
- 120
- Starts
- 2009-06-01
- Expected to finish
- 2026-06-01
- Last updated by the study team
- 2026-06-16
Who can join
Age: 18 and older, up to 90. Sex: any. Healthy volunteers: accepted.
Where it is running
- Memorial Hermann Hospital — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.